Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study

By Blini Mirella   Rossi Gemma Caterina Maria   Trabucchi Giuseppe   Curatola Maria R.   David Alessandro   Radaelli Rosella   Merlo Giancarlo   Ratiglia Roberto  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 57-63

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension

By Suzuki Emilio Rintaro   Meirelles Franklin Luciana   da Silva Luciano José Basilio   Figueiredo Carlos R. L.   Agostini Netto Joao   Batista Wagner Duarte  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1799-1805

Informa Healthcare

Access to resources Recommend Favorite

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

By Day Douglas G.   Hollander David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1435-1442

Informa Healthcare

Access to resources Recommend Favorite

Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost

By Kaback Martin   Geanon John   Katz Gregory   Ripkin Douglas   Przydryga Johan    

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1341-1345

Informa Healthcare

Access to resources Recommend Favorite

Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension

By Orme M.   Collins S.   Dakin H.   Kelly S.   Loftus J.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 511-528

Informa Healthcare

Access to resources Recommend Favorite